Enveric Biosciences
ENVB
ENVB
18 hedge funds and large institutions have $4.64M invested in Enveric Biosciences in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
29% more funds holding
Funds holding: 14 → 18 (+4)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Holders
18
Holding in Top 10
–
Calls
$740K
Puts
$109K
Top Buyers
| 1 | +$1.07M | |
| 2 | +$680K | |
| 3 | +$194K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$175K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$116K |
Top Sellers
| 1 | -$136K | |
| 2 | -$52K | |
| 3 | -$19.4K | |
| 4 |
S
SignatureFD
Atlanta,
Georgia
|
-$19.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$19.4K |